Xoc Pharmaceuticals

Xoc Pharmaceuticals is an early-stage biopharmaceutical company focused on the development of innovative therapies. We design new products "from the ground up" to address unmet medical needs, primarily in the field of central nervous system disorders, by leveraging information from existing compounds with established pharmacological and clinical histories and utilizing the company’s proprietary design and development processes. The company’s initial areas of focus are the development of novel oral therapies for migraine prevention and dopamine agonists for Parkinson’s disease management.